Back to Trades
Other4
180 Life Sciences Corp.
ATNF
Total Value
$546.1K
Company Information
- Company Name
- 180 Life Sciences Corp.
- Ticker Symbol
- ATNF
- CIK
- 0001690080
Insider Information
- Role
- Director
- Location
- PALO ALTO, CA
Director
Filing Details
- Filing Date
- Aug 11, 2025
- Transaction Date
- Aug 8, 2025
- Accession Number
- 0001213900-25-074509
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Aug 8, 2025 | Derivative | 181,422 | $3.01 | Grant/Award | $546.1K |
Footnotes
- (F1)The options were granted under the 2025 Second Supplemental Option Plan of the Issuer. The options vested immediately, but are not exercisable until stockholder approval of the 2025 Second Supplemental Option Plan is received. If stockholder approval is not received prior to August 8, 2026, the options will be cancelled.
- (F2)Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a director of the Issuer.